MRNACAUTIOUS

MRNA Gross Margin Analysis

35.0%

Updated 6h ago·SEC filings & market data

Key Takeaway

Gross margin is the percentage of revenue left after subtracting the direct costs of producing a product, so MRNA's 35.0% means it keeps $0.35 for every $1 of sales before other expenses.

Sector Performance

28th percentile

MRNA

35.0%

Sector Median

46.6%

Sector Avg

47.6%

Prior Period

-145.5%(May 2026)

↑ Improving
📊

Deep Analysis

Gross margin is the percentage of revenue left after subtracting the direct costs of producing a product, so MRNA's 35.0% means it keeps $0.35 for every $1 of sales before other expenses.

Against sector peers, this sits well below the 45.6% median, placing MRNA in the 31st percentile—meaning roughly two-thirds of peers retain a larger share of revenue. The trend cannot be assessed because the year-over-year change is N/A, the quarter-over-quarter change is N/A, and the last-eight-quarter direction is also N/A; only the current 35.0% figure is available. A low margin at an unknown trajectory creates uncertainty: if 35.0% reflects a new normal, MRNA has less buffer to absorb costs than most peers, but without trend data you cannot tell if this is improving or worsening. This metric directly contradicts the overall CAUTIOUS verdict, because the cautious stance is supported by a below-median margin and a lack of historical context to confirm stability.

Frequently Asked Questions

What does the Gross Margin tell investors about MRNA?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

Who are MRNA's closest peers by Gross Margin?

The closest peers by Gross Margin include: LVS (46.9%), ORLY (51.4%), MPWR (55.2%), NEM (56.0%), REI (56.0%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

Advertisement

Master MRNA's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full MRNA research report

Free account — no credit card

MRNA

35.0%

Sector Median

46.6%

Sector Avg

47.6%

How MRNA's Gross Margin compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.